Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Patient Experience During Treatment for Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01553825
Recruitment Status : Recruiting
First Posted : March 14, 2012
Last Update Posted : May 2, 2019
Sponsor:
Information provided by (Responsible Party):
Stanford University

Brief Summary:
Assessing the mindset of cancer patients will help us better understand which patients are having difficulty dealing with the diagnosis and treatment that may not otherwise be fully appreciated by their physicians. By identifying such patients, we may then be able to design and implement strategies that can help improve their coping skills both during the treatment as well as after the completion of treatment. In addition to addressing physical concerns and symptoms, this approach will help address the overall emotional impact of a cancer diagnosis as more patients are living as cancer survivors.

Condition or disease
Carcinoma

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of Patient Experience During Treatment for Cancer
Actual Study Start Date : March 2012
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Group/Cohort
Pathologically diagnosed carcinoma




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Pathologically diagnosed carcinoma patients at Stanford cancer center who signed the informed consent form.
Criteria

Inclusion Criteria:

  • Pathologically diagnosed carcinoma patients at Stanford cancer center who signed the informed consent form.

Exclusion Criteria:

  • Patients with a prognosis of < 6 months life expectancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01553825


Contacts
Layout table for location contacts
Contact: Paulina Gutkin 650-736-0921 pgutkin@stanford.edu

Locations
Layout table for location information
United States, California
Stanford University, School of Medicine Recruiting
Palo Alto, California, United States, 94305
Contact: Paulina Gutkin    650-736-0921    pgutkin@stanford.edu   
Principal Investigator: Kathleen C Horst, MD         
Sub-Investigator: Oxana Palesh, MD         
Sponsors and Collaborators
Stanford University
Investigators
Layout table for investigator information
Principal Investigator: Kathleen Horst Stanford University

Layout table for additonal information
Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01553825     History of Changes
Other Study ID Numbers: IRB-22490
SU-03082012-9290 ( Other Identifier: Stanford University )
VAR0075 ( Other Identifier: OnCore )
IRB-22490 ( Other Identifier: Stanford IRB )
First Posted: March 14, 2012    Key Record Dates
Last Update Posted: May 2, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No